We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biochip Diagnoses Sepsis in Blood Samples

By LabMedica International staff writers
Posted on 28 Dec 2011
A new biochip will enable physicians to analyze blood for sepsis without having to send the sample to a central laboratory. More...


The more quickly and directly doctors recognize and treat sepsis, the greater the patient's chances of survival and speed can save lives especially in the case of blood poisoning.

A biochip device developed by scientists at the Fraunhofer Institute for Physical Measurement Techniques, (IPM; Freiburg, Germany) prepares the blood sample by separating the red blood cells from the blood and the plasma that remains is guided onto the biochip. In patients, who are suffering from sepsis, their immune system reacts by producing certain proteins. There are antibodies positioned on the chip, which fit these proteins as a key fits a lock. If the proteins are present in the blood, the antibodies fish them out of the fluid and bind them to the chip.

The apparatus distinguishes many tiny illuminated dots that show the protein was in the blood. If the patient is healthy, however, the chip remains dark. The scientists can even test for different proteins at the same time in one cycle. This is done by placing various different catcher molecules on the chip, to which specific molecules in the blood attach themselves. An ingenious selection of proven protein markers allows the investigators to obtain additional important information about the severity and cause of the illness.

Together with colleagues from a university hospital, the scientists have already successfully tested prototypes of the device and biochip. Each biochip can only be used once so they have to be affordable. Albrecht Brandenburg, PhD, a professor and group manager at IPM, said, "We predict that in the long run, with production on a large enough scale, each chip will cost no more than one euro. There are various possible applications: other conditions such as heart attacks or cancers can also be investigated in this way. What's more, the chip facilitates doping and urine testing."

Related Links:

Fraunhofer Institute for Physical Measurement Techniques



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more

Pathology

view channel
Image: Spatial characterization of immune–tumor interactions and treatment response across SCLC and extended phenotype models (Cristian Barrera et al, npj Precision Oncology (2026). DOI: 10.1038/s41698-025-01225-9)

AI Pathology Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.